Here’s a summary of Covid-19 variants and also vaccine efficacy for most of the top vaccines in use against the two main variants.
(sources used for this article list below)
(first published 11/06/21, updated 26/07/21)
VARIANTS on SARS Cov-2 (Wuhan), Dec. 2019
EPSILON — B.1.427/B.1.429 (USA) March 2020
ZETA — P2 — Brazil April 2020
BETA — B1351 (South Africa) May. 2020
ALPHA — B117 (UK) First detected — Sept. 2020
KAPPA B.1.617 (India) October 2020
DELTA B1617.2 (India) Oct. 2020
GAMMA — P1 (Brazil) Nov. 2020
IOTA B.1.526 (USA) Nov 2020
ETA — B.1.525 (various) Dec 2020
THETA — P3 (Philippines) Jan 2021
Delta is 40–64% more transmissible than Alpha and requires 83% of a population to be immunized to achieve herd immunity. In Thailand, 8% of infections are the Delta variant, while in the UK the figure is 96%, and the UK is expected to extend its lockdown rules. One third of UK patients infected with Delta ended up in hospital, despite having received their first dose of a vaccine, revealing the variant’s resistance to vaccine. To date 61.5% of the UK has received a first dose, and 43.7% a second dose.
The Alpha variant is also more transmissible than the original virus, but less so than the Delta, and requires 75% of the population to be vaccination to achieve herd immunity. It’s the dominant strain in Thailand (88% of infections).
The Beta variant has begun to emerge in some places as a concern and has been noted as “somewhat resistant” to vaccines, although the variant is also less transmissible.
VACCINES & VARIANTS
Note that all vaccines provide very high (90–100%) protection from the need to be hospitalized or death, so the focus here is on data related to how well the vaccines provide protection against symptoms, or infection.
Vaccines & the Alpha Variant
Astra Zeneca — 74% against symptoms
Sinopharm — 73%,
Sinovac — ___61%,
Pfizer (mrna) 96%
J&J 72%, 72%
Moderna (mrna) — 94%,
Vaccines & the Delta Variant
AstraZeneaca — 35% against symptoms,(92% protection from hospitalization)
Sinovac (no data)
Sinopharm — 47% against symptoms
Pf izer— (updated 07/26 based on data from Israeli government) — 39% against infection, 40% against symptoms, 88% against hospitalization, 91% against severe Covid and death,
J&J 64% against symptoms
Moderna 89% against symptoms
Sinovac — There was no readily available data on its Delta efficacy. On the Gamma and Zeta variants, the WHO reported a 51% efficacy against symptoms ,100% against need for hospitalization, with no data on protection from infection.
There is evidence that a third shot of the AstraZeneca vaccine, given six months after the second dose, acts as an effective booster, including protection from the Beta variant.
Astra Zeneca Quality Control — The vaccines are approved by WHO. Siam Bioscience manufacturing facilities exist in Europe, and in Thailand. The Euro manufactured vaccines have been given approval by outside agencies. In regards, to vaccines made in their Thai facilities, “…samples from test batches of the COVID-19 vaccine made by Siam Bioscience (in Thailand) had passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the U.S.
Sinopharm — the data is based on smaller sample sizes. The vaccine is easier to distribute as the cold storage requirements are less extreme, “Its easy storage requirements make it highly suitable for low-resource settings. It is the also first vaccine that will carry a vaccine vial monitor, a small sticker on the vaccine vials that change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used.”
Alpha variant '88% dominant' in kingdom
UK strain deadliest but jabs can beat it Easy does it: A nurse administers a Covid-19 vaccine jab to a monk at Wat Bang…
Tracking SARS-CoV-2 variants
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no…
COVID-19 vaccine efficacy summary
To project future COVID-19 trends, IHME centralizes and updates all available data on vaccine efficacy. This document…
The Sinovac COVID-19 vaccine: What you need to know
The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of…
Sinovac, Pfizer/BioNtech COVID-19 vaccines prove highly effective in Uruguay -government
Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech's (SVA.O) COVID-19 vaccine among its…
AstraZeneca's COVID-19 vaccines made by Siam Bioscience pass quality testing in Europe and U.S…
Siam Bioscience produced vaccines passes the numerous quality control tests at AstraZeneca's global analytical…
Siam Bioscience-produced AstraZeneca vaccine passes quality testing
Siam Bioscience-produced AstraZeneca vaccine passes quality testing A health worker holds a syringe and a vial of the…
Sinopharm's two COVID-19 shots effective, study says
Two COVID-19 vaccines from China's Sinopharm showed more than 70% efficacy against symptomatic cases, but it remains…
England's lockdown easing on 21 June likely to be delayed by up to four weeks
The lifting of all lockdown restrictions in England is likely to be delayed for up to a month from the planned date of…
Structural Changes Identified in COVID Alpha and Beta Variants - Suggests Need for Updated Vaccine…
Changes to the 'spike' protein explain Alpha's faster spread, and how the Beta variant evades immune responses…
Third shot of AstraZeneca vaccine could work as booster - study
A third shot of the Oxford/AstraZeneca vaccine could be an effective booster jab without the need for tweaks, research…